Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jan 12, 2024
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- Topic Areas of Interest for Joint NIH/NSF Science of Science Approach to Analyzing and Innovating the Biomedical Research Enterprise (SoS:BIO) Program
(NOT-GM-24-020)
National Institute of General Medical Sciences
- Notice of Early Expiration and Reissuance of RFA-HG-24-006: "NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)"
(NOT-HG-24-014)
National Human Genome Research Institute
- 2024 NIH Grants Policy Updates Join this Virtual Event on Wednesday, January 31 Register Today!
(NOT-OD-24-054)
Office of the Director, NIH
- Notice of Participation of the All of Us Research Program in PA-23-189: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp-Clinical Trial Not Allowed)
(NOT-PM-24-002)
Office of the Director, NIH
- Request for Information: Soliciting Input on a Proposed Traumatic Brain Injury (TBI) Classification System
(NOT-NS-24-027)
National Institute of Neurological Disorders and Stroke
- Request for Information (RFI): Increasing the usability of Common Fund data resources by researchers from underrepresented groups
(NOT-RM-24-001)
Office of Strategic Coordination (Common Fund)
Notice of Changes to Funding Opportunities
- Notice of Change to Application Due Date for RFA-DA-22-040, "High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)"
(NOT-DA-23-041)
National Institute on Drug Abuse
- Notice of Change to Open Date for PAR-24-048, "Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)"
(NOT-DA-23-051)
National Institute on Drug Abuse
- Notice of Change RFA-EB-23-005, "Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)"
(NOT-EB-24-003)
National Institute of Biomedical Imaging and Bioengineering
- Notice of NIEHS Participation in PAR-24-075 and PAR-24-076, Stephen I. Katz Early Stage Investigator Research Project Grant (R01) Notices of Funding Opportunity
(NOT-ES-24-005)
National Institute of Environmental Health Sciences
- Notice of NIMH Participation in PAR-24-075 and PAR-24-076 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) and (Parent R01 Basic Experimental Studies with Humans Required)
(NOT-MH-24-160)
National Institute of Mental Health
- RESCINDED - Notice of Participation of NIMH in PAR-24-076, "Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)"
(NOT-MH-24-161)
National Institute of Mental Health
- Notice of Change: Extension of PAR-21-237 "NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)" by two council rounds
(NOT-NS-24-033)
National Institute of Neurological Disorders and Stroke
- Notice of Change to Funding Opportunity: Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
(NOT-TW-24-001)
John E. Fogarty International Center
Notices of Special Interest
- Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace
(NOT-MH-24-115)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Funding Opportunities
- Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
(PAR-24-060)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism - Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)
(PAR-24-078)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Office of AIDS Research - Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional)
(PAR-24-106)
National Human Genome Research Institute - Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional)
(PAR-24-107)
National Human Genome Research Institute - Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult Services (U01 Clinical Trials Optional)
(RFA-HG-24-001)
National Human Genome Research Institute - NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-HG-24-013)
National Human Genome Research Institute
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 313-335-2123, or email Ann Ricketts or Lynn Hudachek.